C. La Rosa

发表

Thiol precursors in Catarratto Bianco Comune and Grillo grapes and effect of clarification conditions on the release of varietal thiols in wine

I. De Noni, D. Fracassetti, M. Stuknytė, 2018 .

CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells

Xiuli Wang, J. Zaia, A. Mardiros, 2015, Clinical Cancer Research.

Immunization with Th-CTL Fusion Peptide and Cytosine-Phosphate-Guanine DNA in Transgenic HLA-A2 Mice Induces Recognition of HIV-Infected T Cells and Clears Vaccinia Virus Challenge 1

R. Siliciano, C. Buck, J. Longmate, 2003, The Journal of Immunology.

Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients.

S. Forman, D. Senitzer, D. Diamond, 2014, Transplant immunology.

Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.

B. Williams, J. Zaia, A. Krieg, 2012, The Journal of infectious diseases.

Recombinant Modified Vaccinia Virus Ankara Expressing a Soluble Form of Glycoprotein B Causes Durable Immunity and Neutralizing Antibodies against Multiple Strains of Human Cytomegalovirus

W. Britt, J. Longmate, D. Diamond, 2004, Journal of Virology.

Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants

Anna M. Acosta, P. Frankel, J. Zaia, 2022, iScience.

Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity

I. Aldoss, J. Zaia, S. Forman, 2022, Blood Advances.

Programmed death-1 expression in liver transplant recipients as a prognostic indicator of cytomegalovirus disease.

A. Limaye, J. Longmate, D. Diamond, 2008, The Journal of infectious diseases.

The immune response to human CMV.

D. Diamond, C. La Rosa, 2012, Future virology.

Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1.

W. Britt, D. Diamond, Zhongde Wang, 2007, Vaccine.

Kinase‐Deficient CMVpp65 Triggers a CMVpp65 Specific T‐Cell Immune Response in HLA‐A*0201.Kb Transgenic Mice after DNA Immunization

J. Zaia, D. Diamond, G. Gallez-Hawkins, 2002, Scandinavian journal of immunology.

Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease.

A. Limaye, J. Longmate, D. Diamond, 2007, The Journal of infectious diseases.

Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes

J. York, D. Senitzer, J. Longmate, 2000, Immunogenetics.

Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant Recipients

A. Limaye, J. Longmate, D. Diamond, 2016, Transplantation.

Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients

A. Limaye, J. Longmate, D. Diamond, 2011, Transplant international : official journal of the European Society for Organ Transplantation.

Human Cytomegalovirus Vaccine Based on the Envelope gH/gL Pentamer Complex

A. Herrmann, Erica L Johnson, P. Barry, 2014, PLoS pathogens.

Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope

M. Bendinelli, S. Specter, G. Malvaldi, 1993, Journal of virology.

A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models.

D. Diamond, Zhongde Wang, P. Manchanda, 2008, Immunology letters.

Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice

D. Diamond, Heidi Contreras, Soojin Park, 2018, Journal of Virology.

Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells.

R. Siliciano, W. Britt, C. Buck, 2004, Blood.

The antiviral activity of a synthetic peptide derived from the envelope SU glycoprotein of feline immunodeficiency virus maps in correspondence of an amphipathic helical segment.

M. Bendinelli, P. Rovero, C. Garzelli, 1998, Biochemical and biophysical research communications.

A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection

J. Zaia, D. Diamond, Sanjeet S. Dadwal, 2018, Expert review of vaccines.

Characterization of host immunity to cytomegalovirus pp150 (UL32).

D. Diamond, S. Lacey, Zhongde Wang, 2005, Human immunology.

Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients.

A. Limaye, J. Zaia, Lia Thao, 2006, The Journal of infectious diseases.

Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles.

M. Villacres, J. Zaia, S. Forman, 2003, Human immunology.

Most potential linear B cell epitopes of Env glycoproteins of feline immunodeficiency virus are immunogenically silent in infected cats.

M. Bendinelli, C. Garzelli, S. Lombardi, 1997, AIDS research and human retroviruses.

Epitope mapping of the V3 domain of feline immunodeficiency virus envelope glycoprotein by monoclonal antibodies.

M. Bendinelli, C. Garzelli, S. Lombardi, 1995, The Journal of general virology.

Mamu-A01/K(b) transgenic and MHC Class I knockout mice as a tool for HIV vaccine development.

P. Barry, J. Longmate, E. Manuel, 2009, Virology.

MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.

I. Aldoss, J. Zaia, J. Longmate, 2017, Blood.

Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice.

H. Andersson, S. Forman, L. Cooper, 2011, Blood.

Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients

A. Nademanee, I. Aldoss, S. Forman, 2020, Annals of Internal Medicine.

Intergenic region 3 of modified vaccinia ankara is a functional site for insert gene expression and allows for potent antigen-specific immune responses.

E. Manuel, D. Diamond, Zhongde Wang, 2010, Virology.

In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.

J. Longmate, D. Diamond, S. Lacey, 2006, Experimental hematology.

Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice.

M. Villacres, D. Diamond, S. Lacey, 2002, Blood.

Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.

W. Britt, D. Diamond, S. Lacey, 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax.

I. Aldoss, J. Longmate, D. Diamond, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax.

I. Aldoss, J. Longmate, D. Diamond, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries.

R. Houghten, C. Pinilla, D. Diamond, 2001, Blood.

Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial.

I. Aldoss, Jeffrey S. Miller, J. Zaia, 2016, The Lancet. Haematology.

Infrequent Occurrence of Natural Mutations in the pp65495–503 Epitope Sequence Presented by the HLA A∗0201 Allele among Human Cytomegalovirus Isolates

J. Zaia, D. Diamond, Xiuli Li, 2001, Journal of Virology.

Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines

Zhongde Wang, Anindya Dasgupta, W. Britt, 2009, Vaccine.

A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector.

W. Britt, A. Mandarino, J. Zaia, 2008, Virology.

Programmed death‐1 receptor and interleukin‐10 in liver transplant recipients at high risk for late cytomegalovirus disease

D. Diamond, S. Lacey, A. Limaye, 2010, Transplant infectious disease : an official journal of the Transplantation Society.

CMV Triplex vaccine to enhance adaptive NK and T-cell reconstitution after autologous hematopoietic cell transplantation.

D. Weisdorf, A. Rashidi, D. Diamond, 2022, Transplantation and cellular therapy.

Cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic hematopoietic stem cell transplantation: viremia, immunogenicity and survival outcomes in a randomised phase 1b trial

I. Aldoss, Jeffrey S. Miller, J. Zaia, 2015, The Lancet. Haematology.

Hematopoietic stem cell donor vaccination with cytomegalovirus triplex augments frequencies of functional and durable cytomegalovirus‐specific T cells in the recipient: A novel strategy to limit antiviral prophylaxis

I. Aldoss, D. Diamond, A. Artz, 2023, American journal of hematology.

Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study

G. Marcucci, I. Aldoss, S. Forman, 2023, Frontiers in Immunology.

Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial

A. Sette, P. Frankel, J. Zaia, 2022, The Lancet Microbe.

Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.

M. Villacres, J. Zaia, J. Longmate, 2001, The Journal of infectious diseases.

Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.

M. Bendinelli, P. Rovero, C. Garzelli, 1996, Virology.

The Incidence of Depression and the Decrease of Quality of Life in Patients with Moderate-Severe Inflammatory Acne

C. La Rosa, C.A. Verdeja-Robles, A. Gutiérrez-Morgas, 2019 .

Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms’ tumor antigen in patients with non-Hodgkin lymphoma

A. Rosenwald, J. Zaia, S. Forman, 2013, Leukemia & lymphoma.

Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice.

H. Andersson, S. Forman, L. Cooper, 2011, Blood.

Adoptive transfer of functional SARS‐COV‐2‐specific immunity from donor graft to hematopoietic stem cell transplant recipients

S. Forman, D. Diamond, V. Pullarkat, 2022, American journal of hematology.